Such individuals might be under-represented in the APOE+ and/or amyloid+ groups, which are enriched for Alzheimer’s disease, and thus more prevalent in the APOE− and amyloid− groups. The gene discussed is APOE; the disease is early-onset autosomal dominant Alzheimer disease.